FI20115670A0 - Kardiovaskulaarinen in vitro-malli - Google Patents

Kardiovaskulaarinen in vitro-malli

Info

Publication number
FI20115670A0
FI20115670A0 FI20115670A FI20115670A FI20115670A0 FI 20115670 A0 FI20115670 A0 FI 20115670A0 FI 20115670 A FI20115670 A FI 20115670A FI 20115670 A FI20115670 A FI 20115670A FI 20115670 A0 FI20115670 A0 FI 20115670A0
Authority
FI
Finland
Prior art keywords
cardiovascular model
relates
model
platform
vitro
Prior art date
Application number
FI20115670A
Other languages
English (en)
Swedish (sv)
Inventor
Katriina Aalto-Setaelae
Tuula Heinonen
Erja Kerkelae
Jertta-Riina Sarkanen
Hanna Vuorenpaeae
Timo Ylikomi
Original Assignee
Tampereen Yliopisto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tampereen Yliopisto filed Critical Tampereen Yliopisto
Priority to FI20115670A priority Critical patent/FI20115670A0/fi
Publication of FI20115670A0 publication Critical patent/FI20115670A0/fi
Priority to JP2014516404A priority patent/JP2014519837A/ja
Priority to EP12803040.0A priority patent/EP2723853B1/en
Priority to PCT/FI2012/050611 priority patent/WO2012175797A1/en
Priority to CA2839052A priority patent/CA2839052A1/en
Priority to CN201280030909.0A priority patent/CN103814124A/zh
Priority to BR112013033246A priority patent/BR112013033246A2/pt
Priority to DK12803040.0T priority patent/DK2723853T3/en
Priority to KR1020147000113A priority patent/KR20140048190A/ko
Priority to US14/128,766 priority patent/US20140206029A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1352—Mesenchymal stem cells
    • C12N2502/1382—Adipose-derived stem cells [ADSC], adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/28—Vascular endothelial cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
FI20115670A 2011-06-23 2011-06-23 Kardiovaskulaarinen in vitro-malli FI20115670A0 (fi)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FI20115670A FI20115670A0 (fi) 2011-06-23 2011-06-23 Kardiovaskulaarinen in vitro-malli
JP2014516404A JP2014519837A (ja) 2011-06-23 2012-06-14 インビトロの心臓血管モデル
EP12803040.0A EP2723853B1 (en) 2011-06-23 2012-06-14 In vitro cardiovascular model
PCT/FI2012/050611 WO2012175797A1 (en) 2011-06-23 2012-06-14 In vitro cardiovascular model
CA2839052A CA2839052A1 (en) 2011-06-23 2012-06-14 In vitro cardiovascular model
CN201280030909.0A CN103814124A (zh) 2011-06-23 2012-06-14 体外心血管模型
BR112013033246A BR112013033246A2 (pt) 2011-06-23 2012-06-14 modelo cardiovascular in vitro
DK12803040.0T DK2723853T3 (en) 2011-06-23 2012-06-14 In vitro cardiovascular model
KR1020147000113A KR20140048190A (ko) 2011-06-23 2012-06-14 시험관내 심혈관 모델
US14/128,766 US20140206029A1 (en) 2011-06-23 2012-06-14 In vitro cardiovascular model

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20115670A FI20115670A0 (fi) 2011-06-23 2011-06-23 Kardiovaskulaarinen in vitro-malli

Publications (1)

Publication Number Publication Date
FI20115670A0 true FI20115670A0 (fi) 2011-06-23

Family

ID=44206878

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20115670A FI20115670A0 (fi) 2011-06-23 2011-06-23 Kardiovaskulaarinen in vitro-malli

Country Status (10)

Country Link
US (1) US20140206029A1 (fi)
EP (1) EP2723853B1 (fi)
JP (1) JP2014519837A (fi)
KR (1) KR20140048190A (fi)
CN (1) CN103814124A (fi)
BR (1) BR112013033246A2 (fi)
CA (1) CA2839052A1 (fi)
DK (1) DK2723853T3 (fi)
FI (1) FI20115670A0 (fi)
WO (1) WO2012175797A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104940997A (zh) * 2014-03-27 2015-09-30 复旦大学 一种组织工程化人类心肌组织
CN105838670A (zh) * 2015-01-13 2016-08-10 上海交通大学医学院附属第九人民医院 一种细胞混合物及其制备方法和用途
US20190017029A1 (en) * 2016-02-25 2019-01-17 The J. David Gladstone Institutes, a testament trust established under the Will of J. David Generation of Expandable Cardiovascular Progenitor Cells
CN105911096B (zh) * 2016-03-29 2018-07-10 南京艾尔普再生医学科技有限公司 一种可以体外进行药物药理毒理筛查的人工心脏系统
IT201800007946A1 (it) * 2018-08-07 2020-02-07 1Lab Sa Modello per simulare in-vitro il comportamento di vasi disfunzionali
EP3950711A4 (en) * 2019-04-01 2022-12-21 Toppan Inc. CELL CONSTRUCT AND METHODS OF PRODUCTION
CN111793609B (zh) * 2020-09-08 2020-12-29 北京达熙生物科技有限公司 一种促进脂肪干细胞增殖和分化的方法
JPWO2022113540A1 (fi) * 2020-11-26 2022-06-02

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002078439A2 (en) * 2001-03-30 2002-10-10 The Arizona Board Of Regents On Behalf Of The University Of Arizona Prevascularized constructs for implantation to provide blood perfusion
US7052829B2 (en) * 2001-03-30 2006-05-30 The Arizona Board Of Regents On Behalf Of The University Of Arizona Prevascularized constructs for implantation to provide blood perfusion
AU2003220424A1 (en) * 2002-03-19 2003-10-08 Advanced Research And Technology Transfer Adipose stromal stem cells for tissue and vascular modification
FR2859381B1 (fr) * 2003-09-05 2008-07-25 Centre Nat Rech Scient Utilisaton de cellules issues du tissu adipeux pour induire la formation d'un reseau vasculaire fonctionnel
RU2334793C1 (ru) 2007-02-20 2008-09-27 Федеральное Государственное Учреждение "Российский кардиологический научно-производственный комплекс Федерального агентства по здравоохранению и социальному развитию" Способ получения культуры клеток с индуцированным ангиогенным фенотипом, предназначенной для тканевой инженерии в зоне ишемии
ES2325715B1 (es) 2007-08-03 2010-06-17 Genetrix, S.L. Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
US20090169521A1 (en) 2007-12-31 2009-07-02 Technion Research & Development Foundation Ltd. Vascularized cardiac tissue and methods of producing and using same
WO2010017378A2 (en) * 2008-08-08 2010-02-11 Indiana University Research And Technology Corporation Methods and compositions for vasculogenic potential determination
US8727965B2 (en) * 2010-03-05 2014-05-20 Tissue Genesis, Inc. Methods and compositions to support tissue integration and inosculation of transplanted tissue and transplanted engineered penile tissue with adipose stromal cells

Also Published As

Publication number Publication date
JP2014519837A (ja) 2014-08-21
DK2723853T3 (en) 2018-04-16
CA2839052A1 (en) 2012-12-27
EP2723853B1 (en) 2017-12-27
BR112013033246A2 (pt) 2017-03-01
US20140206029A1 (en) 2014-07-24
WO2012175797A1 (en) 2012-12-27
EP2723853A4 (en) 2015-07-22
CN103814124A (zh) 2014-05-21
EP2723853A1 (en) 2014-04-30
KR20140048190A (ko) 2014-04-23

Similar Documents

Publication Publication Date Title
FI20115670A0 (fi) Kardiovaskulaarinen in vitro-malli
BR112014005355A2 (pt) células t de memória central anti-terceiro, métodos de produção e uso das mesmas em transplante e tratamento de doença
GT201400162A (es) Composición y método para el diagnóstico y el tratamiento de las enfermedades asociadas a la degeneración de las neuritas
AR079889A1 (es) Antagonistas de wnt y metodos de tratamiento y deteccion
WO2012149299A3 (en) Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
EP2826855A4 (en) METHOD FOR PRODUCING MIXTURE OF CARDIAC AND VASCULAR CELLS FROM ARTIFICIAL PLURIPOTENT STEM CELLS
BR112013024574A2 (pt) polipeptídeo, uso, método de tratamento de indivíduos portadores de doenças e método de tratamento de indivíduos que possuem doenças com um polipeptídeo
BR112014005752A2 (pt) plataforma para tecidos e órgãos implantáveis produzidos por engenharia tecidual e métodos para sua produção
BR112013010015A2 (pt) aparelho e método para detecção não invasiva de doenças que afetam as propriedades estruturais em tecidos biológicos
EE05601B1 (et) Seade ja meetod pehme bioloogilise koe mehaanilise pingeseisundi, elastsuse, dnaamilise j„ikuse, roomavuse ja mehaanilise pinge relaksatsiooniaega iseloomustavate parameetrite samaaegseks m??tmiseks reaalajas ning arvutiprogrammi produkt
ECSP14002542A (es) Nuevos 2h–indazoles como antagonistas del receptor ep2
EA201591742A1 (ru) Способ улучшения диагностики заболеваний с использованием измеряемых аналитов
BR112014007007A2 (pt) método de diferenciação precoce, método de diagnóstico de fibrilação, uso de troponina cardíaca, dispositivo de diferenciação e dispositivo de diagnóstico
WO2014140362A3 (en) Lymphocyte biomarkers for determining the clinical response to therapy with mesenschymal stromal cells(msc)
WO2013184193A3 (en) Cancer stem cells and methods of using the same
EP2894219A4 (en) ARTIFICIAL SKIN FABRIC, ARTIFICIAL SKIN MODEL AND METHOD OF MANUFACTURING THE SAME
EP2772760A4 (en) METHOD FOR MEASURING A BIOLOGICAL ACTIVE BIOLOGICAL ACTIVE SUBSTANCE AND MICROPARTICLE AND EXTRACT FOR USE IN THIS METHOD
EP2610337A4 (en) MASS TEST OF BLOOD CELL BLOOD CELLS USING CELL COAGULATION, ADULT BLOOD STEM CELLS USING THE SAME, METHOD OF EXPANDING PROGENITOR CELLS AND STEM CELLS PRODUCED USING THE METHOD
BR112014010166A8 (pt) uso de uma composição para a fabricação de um produto para melhorar a pontuação na bateria de testes neuropsicológicos, método para avaliar a cognição de um indivíduo e uso de uma composição para a fabricação de um produto para tratar um indivíduo em necessidade da mesma
EP2566879A4 (en) METHOD FOR FUNCTIONALIZATION OF HUMAN RED GLOBES USING ANTIBODIES
FR2962443B1 (fr) Modele de tissu adipeux et procede de preparation
EA201301080A1 (ru) Применение солей 3-карбокси-n-этил-n,n-диметилпропан-1-аммония при лечении сердечно-сосудистого заболевания
EP2903507A4 (en) ELECTRO-MECHANICAL MEASUREMENT OF THE ACTIVITY OF STAPEDIUS MUSCLES / SIDS
RU2012118140A (ru) Способ индивидуального назначения системной пульс-терапии глюкокортикостероидами пациентам с эндокринной офтальмопатией
UA74784U (ru) Способ оценки состояния миокарда левого желудочка, преимущественно, после стентирования коронарных артерий

Legal Events

Date Code Title Description
FD Application lapsed